Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0793
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2639
    +0.0017 (+0.13%)
     
  • USD/JPY

    151.2360
    -0.1360 (-0.09%)
     
  • Bitcoin USD

    69,965.27
    -1,230.31 (-1.73%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

U.S. FDA panel backs approval of Pfizer's opioid painkiller

June 8 (Reuters) - A U.S. advisory panel on Wednesday recommended approval of Pfizer Inc's long-acting opioid painkiller Troxyca ER, saying it dulls pain and may deter people from snorting or injecting it.

The panel concluded that the drug does not deter abuse by those seeking to manipulate and swallow the drug. The FDA is not obliged to follow the advice of its advisory panels but typically does so.

(Reporting by Toni Clarke in Washington, editing by G Crosse)

Advertisement